A mother battling a terminal illness has successfully raised over £50,000 from public donations after making a heartfelt plea for funding for the life-prolonging Enhertu drug. Jess Duggan, 44, expressed gratitude for the overwhelming support she received, describing it as “amazing.” With the funds raised privately, she has started treatment with the drug and cherished special moments with her children, hoping to witness more milestones in the future.
The situation highlights the disparity in access to the Enhertu drug, which is available in Scotland and numerous European countries but not in England, Wales, and Northern Ireland. Jess’s story has resonated with the public, as evidenced by a recent survey showing strong support for making the drug accessible through the National Health Service (NHS).
Despite facing a dire prognosis, Jess remains resilient in her advocacy efforts to make the drug widely available. She commended the kindness of strangers and loved ones who contributed to her cause, emphasizing the urgent need for affordable access to the treatment. Jess is calling on the Health Secretary to prioritize funding for the drug, which has been declined due to cost concerns.
Having received a short life expectancy diagnosis, Jess took the courageous step to seek financial assistance for the Enhertu drug, known to extend life expectancy by six months. She emphasized the financial strain associated with the treatment, including additional costs beyond the drug itself. Sharing her experience, Jess highlighted the challenges of navigating private healthcare options and expressed gratitude for the supportive individuals involved in her fundraising efforts.
As Jess continues her battle against cancer, she remains hopeful that the Enhertu treatment will offer her more time with her loved ones. Her story underscores the urgent need for policy changes to ensure equitable access to life-extending medications for all patients in need.